Annals of Surgical Oncology

, Volume 2, Issue 6, pp 537–541 | Cite as

Improved survival after resection of colorectal liver metastases

  • George M. Fuhrman
  • Steven A. Curley
  • David C. Hohn
  • Mark S. Roh
Original Articles

Abstract

Background: The goal of this study was to determine if staging with intraoperative ultrasound (IOUS), assessment of porta hepatis lymph nodes, and evaluation of resection margins can improve selection of patients likely to benefit from resection of colorectal liver metastases.

Methods: A retrospective evaluation was performed on patients undergoing celiotomy with intent to resect colorectal liver metastases. Patients were considered unresectable if extrahepatic disease was identified by peritoneal exploration or if IOUS demonstated greater than four lesions or the inability to achieve negative margins. Tumor-negative margins were confirmed by pathologic evaluation. Actuarial 5-year survival was calculated using the method of Kaplan and Meier.

Results: Median follow-up is 25 months. Of the 151 patients undergoing operative exploration, 107 (71.0%) underwent liver resection (all margins tumor negative). Three operative deaths occurred in this group (2.8%). The disease of 30 patients (19.8%) was considered unresectable due to extrahepatic involvement, and that of 14 patients (9.2%) was demonstrated by IOUS to be unresectable. Five-year actuarial survival was 44% for the resected group and 0% for the unresectable patients (p<0.0001).

Conclusions: IOUS, portal node assessment, and pathologic margin evaluation improves the selection of patients likely to benefit from resection of colorectal liver metastases.

Key Words

Colorectal cancer Liver metastases Liver resection Intraoperative ultrasound 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boring CC, Squires TS, Tong T, Mongomery S. Cancer statistics, 1994.CA 1994;44:18.Google Scholar
  2. 2.
    Steele G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer.Ann Surg 1989;210:127–38.PubMedGoogle Scholar
  3. 3.
    Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer.Arch Surg 1984;119:647–51.PubMedGoogle Scholar
  4. 4.
    Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma.Ann Surg 1989;209:428–34.PubMedGoogle Scholar
  5. 5.
    Iwatsuki S, Byers WS, Starzl TE. Experience with 150 liver resections.Ann Surg 1983;197:247–53.PubMedGoogle Scholar
  6. 6.
    Sesto ME, Vogt DP, Hermann RE. Hepatic resection in 128 patients: a 24-year experience.Surgery 1987;102:846–51.PubMedGoogle Scholar
  7. 7.
    Sitzmann JV, Greene PS. Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients.Ann Surg 1994;219:13–7.PubMedGoogle Scholar
  8. 8.
    Steele G, Bleday R, Mayer RJ, Linbald A, Petrelli N, Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584.J Clin Oncol 1991;9:1105–12.PubMedGoogle Scholar
  9. 9.
    Vetto JT, Hughes KS, Rosenstein R, Sugarbaker PH. Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma.Dis Colon Rectum 1990;33:408–13.CrossRefPubMedGoogle Scholar
  10. 10.
    Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indication for resection.Surgery 1988;103:278–88.Google Scholar
  11. 11.
    Boldrini G, deGaetano AM, Giovanni I, et al. The systematic use of operative ultrasound for detection of liver metastasis during colorectal surgery.World J Surg 1987;11:622–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Boutkan H, Luth W, Meyer S, Cuesta M, van Huezen E, Prevoo W. The impact of intraoperative ultrasonography of the liver on the surgical strategy of patients with gastrointestinal malignancies and hepatic metastases.Eur J Surg Oncol 1992;18:342–6.PubMedGoogle Scholar
  13. 13.
    Brower ST, Dumitrescu O, Rubuioff S, et al. Operative ultrasound establishes resectability of metastases by major hepatic resection.World J Surg 1989;13:649–57.CrossRefPubMedGoogle Scholar
  14. 14.
    Olsen AK. Intraoperative ultrasonography and the detection of liver metastases in patients with colorectal cancer.Br J Surg 1990;77:998–9.PubMedGoogle Scholar
  15. 15.
    Rifkin MD, Posato FE, Branch M, et al. Intraoperative ultrasound of the liver, an important adjunctive tool for decision making in the operating room.Ann Surg 1987;205:466–72.PubMedGoogle Scholar
  16. 16.
    Babineva TJ, Lewis D, Jenkins RL, et al. Role of staging laparoscopy in the treatment of the hepatic malignancy.Am J Surg 1994;167:151–5.Google Scholar
  17. 17.
    Gunven P, Makouchi M, Takayasu, et al. Preoperative imaging of liver metastases: comparison of angiography, CT scan, and ultrasonography.Ann Surg 1985;202:573–9.PubMedGoogle Scholar
  18. 18.
    Ward BA, Miller DL, Frank JA, et al. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings.Surgery 1989;105:180–7.PubMedGoogle Scholar
  19. 19.
    Heiken JP, Weyman PJ, Lee JKT, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.Radiology 1989;171:47–51.PubMedGoogle Scholar
  20. 20.
    Cady B, Stone MD, McDermott WV. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases.Arch Surg 1992;127:561–9.PubMedGoogle Scholar
  21. 21.
    Curley SA, Chase JL, Roh MS, et al. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices.Surgery 1993;114:928–35.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc 1995

Authors and Affiliations

  • George M. Fuhrman
    • 2
  • Steven A. Curley
    • 1
  • David C. Hohn
    • 1
  • Mark S. Roh
    • 1
  1. 1.Department of Surgical OncologyThe University of Texas M. D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of SurgeryThe Ochsner ClinicNew OrleansUSA

Personalised recommendations